Sandoz Will Wait A Decade On Amantadine

Patent-Litigation Settlement Permits 2030 Launch

 
• By Aidan Fry
  
Target_2030
Sandoz has agreed to wait until 2030 to launch a generic of Gocovri in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin